This study presents data that 14-3-3η is present in the pre-clinical phase of arthritis development, since there was a greater proportion of positivity of this marker at study entry together with higher expression in a pre-selected cohort of ACPA- and/or RF-positive arthralgia subjects who developed arthritis, compared with those who did not. The gene discussed is PRTN3; the disease is Arthralgia.